OWC Pharmaceutical Research Corp. reported that the safety study of cannabis-based topical ointment, conducted at Shiba Shiba Academic Medical Center, is close to completion as the last healthy volunteer started the treatment three weeks ago. The subject of study is expected to be treated with the ointment during six weeks.